FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302307176> ?p ?o ?g. }

• W4302307176 endingPage "5220" @default.
• W4302307176 startingPage "5211" @default.
• W4302307176 abstract "To provide insights into the diagnosis and management of therapy-related myeloid neoplasms (t-MN) following PARP inhibitors (PARPi).In a French cancer center, we identified and described the profiles of 13 t-MN diagnosed among 37 patients with ovarian cancer referred to hematology consultation for cytopenia under PARPi. Next, we described these 13 t-MN post-PARPi among 37 t-MN post ovarian cancer according to PARPi exposure. Finally, we described 69 t-MN post-PARPi in a national cohort.From 2016 to 2021, cumulative incidence of t-MN was 3.5% (13/373) among patients with ovarian cancer treated with PARPi. At time of hematologic consultation, patients with t-MN had a longer PARPi exposure (9 vs. 3 months, P = 0.01), lower platelet count (74 vs. 173 G/L, P = 0.0005), and more cytopenias (2 vs. 1, P = 0.0005). Compared with t-MN not exposed to PARPi, patients with t-MN-PARPi had more BRCA1/2 germline mutation (61.5% vs. 0%, P = 0.03) but similar overall survival (OS). In the national cohort, most t-MN post-PARPi had a complex karyotype (61%) associated with a high rate of TP53 mutation (71%). Median OS was 9.6 months (interquartile range, 4-14.6). In multivariate analysis, a longer time between end of PARPi and t-MN (HR, 1.046; P = 0.02), olaparib compared with other PARPi (HR, 5.82; P = 0.003) and acute myeloid leukemia (HR, 2.485; P = 0.01) were associated with shorter OS.In a large series, we described a high incidence of t-MN post-PARPi associated with unfavorable cytogenetic and molecular abnormalities leading to poor OS. Early detection is crucial, particularly in cases of delayed cytopenia." @default.
• W4302307176 created "2022-10-06" @default.
• W4302307176 creator A5000436961 @default.
• W4302307176 creator A5002402846 @default.
• W4302307176 creator A5003574664 @default.
• W4302307176 creator A5006830639 @default.
• W4302307176 creator A5007605254 @default.
• W4302307176 creator A5007908757 @default.
• W4302307176 creator A5008450550 @default.
• W4302307176 creator A5010519521 @default.
• W4302307176 creator A5011803879 @default.
• W4302307176 creator A5014838075 @default.
• W4302307176 creator A5017875125 @default.
• W4302307176 creator A5020088855 @default.
• W4302307176 creator A5021770896 @default.
• W4302307176 creator A5023091403 @default.
• W4302307176 creator A5024987845 @default.
• W4302307176 creator A5025155327 @default.
• W4302307176 creator A5027850194 @default.
• W4302307176 creator A5029058538 @default.
• W4302307176 creator A5033070003 @default.
• W4302307176 creator A5033419660 @default.
• W4302307176 creator A5033731496 @default.
• W4302307176 creator A5033805399 @default.
• W4302307176 creator A5036048236 @default.
• W4302307176 creator A5037378188 @default.
• W4302307176 creator A5040751163 @default.
• W4302307176 creator A5041838173 @default.
• W4302307176 creator A5043743398 @default.
• W4302307176 creator A5044622802 @default.
• W4302307176 creator A5046799085 @default.
• W4302307176 creator A5052150142 @default.
• W4302307176 creator A5057106150 @default.
• W4302307176 creator A5063206095 @default.
• W4302307176 creator A5065927270 @default.
• W4302307176 creator A5070207000 @default.
• W4302307176 creator A5070881504 @default.
• W4302307176 creator A5071325908 @default.
• W4302307176 creator A5075625785 @default.
• W4302307176 creator A5081514634 @default.
• W4302307176 creator A5083266654 @default.
• W4302307176 creator A5085579500 @default.
• W4302307176 creator A5086774330 @default.
• W4302307176 creator A5088910124 @default.
• W4302307176 creator A5090063034 @default.
• W4302307176 date "2022-10-06" @default.
• W4302307176 modified "2023-10-18" @default.
• W4302307176 title "Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience" @default.
• W4302307176 cites W187238933 @default.
• W4302307176 cites W2135409663 @default.
• W4302307176 cites W2144395887 @default.
• W4302307176 cites W2301004704 @default.
• W4302307176 cites W2339658711 @default.
• W4302307176 cites W2479332993 @default.
• W4302307176 cites W2557652172 @default.
• W4302307176 cites W2559537906 @default.
• W4302307176 cites W2735192192 @default.
• W4302307176 cites W2893157368 @default.
• W4302307176 cites W2896628407 @default.
• W4302307176 cites W2897430921 @default.
• W4302307176 cites W2906323921 @default.
• W4302307176 cites W2906986535 @default.
• W4302307176 cites W2947826965 @default.
• W4302307176 cites W2975141952 @default.
• W4302307176 cites W2976139792 @default.
• W4302307176 cites W3025598062 @default.
• W4302307176 cites W3046671820 @default.
• W4302307176 cites W3082703113 @default.
• W4302307176 cites W3083429069 @default.
• W4302307176 cites W3093490071 @default.
• W4302307176 cites W3113077828 @default.
• W4302307176 cites W3128675049 @default.
• W4302307176 cites W3136213266 @default.
• W4302307176 cites W3139059474 @default.
• W4302307176 cites W3172495081 @default.
• W4302307176 cites W3193952030 @default.
• W4302307176 cites W3197753516 @default.
• W4302307176 cites W3203113034 @default.
• W4302307176 cites W3205906907 @default.
• W4302307176 cites W3206742055 @default.
• W4302307176 cites W4200557730 @default.
• W4302307176 cites W4207063062 @default.
• W4302307176 cites W4256207606 @default.
• W4302307176 doi "https://doi.org/10.1158/1078-0432.ccr-22-1622" @default.
• W4302307176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36201165" @default.
• W4302307176 hasPublicationYear "2022" @default.
• W4302307176 type Work @default.
• W4302307176 citedByCount "5" @default.
• W4302307176 countsByYear W43023071762023 @default.
• W4302307176 crossrefType "journal-article" @default.
• W4302307176 hasAuthorship W4302307176A5000436961 @default.
• W4302307176 hasAuthorship W4302307176A5002402846 @default.
• W4302307176 hasAuthorship W4302307176A5003574664 @default.
• W4302307176 hasAuthorship W4302307176A5006830639 @default.
• W4302307176 hasAuthorship W4302307176A5007605254 @default.
• W4302307176 hasAuthorship W4302307176A5007908757 @default.
• W4302307176 hasAuthorship W4302307176A5008450550 @default.
• W4302307176 hasAuthorship W4302307176A5010519521 @default.

• next